resTORbio shuts down Phase 3 trial in clinically symptomatic respiratory illness
November 18, 2019Research and Development, Sales and Marketing pharma, resTORbio
US firm resTORbio has revealed its intention to terminate a Phase 3 trial of its oral, selective TORC1 inhibitor RTB101 …
Jazz Pharma sleep disorder drug secures CHMP backing for treatment of excessive daytime sleepiness in Europe
November 18, 2019Research and Development, Sales and Marketing EMA, jazz pharma, narcolepsy, pharma, solriamfetol
Jazz Pharma’s solriamfetol has secured a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human …
Novartis’ Adakveo becomes first FDA-approved P-selectin inhibitor for sickle cell disease
November 18, 2019Sales and Marketing Adakve, Novartis, pharma, sickle cell disease
The FDA has chosen to award Novartis’ Adakveo (crizanlizumab) with marketing authorisation, it has emerged, as a treatment to reduce …
Over half of all anti-vaccine ads on Facebook stem from just two advertisers
November 15, 2019Medical Communications, Research and Development Facebook, anti-vaccine, pharma
A new study has revealed that the largest share of anti-vaccine advertisements on Facebook originate from just two organisations, both …
Shionogi gains US approval in complicated urinary tract infections with Fetroja
November 15, 2019Medical Communications, Sales and Marketing FDA, Fetroja, Shiogoni
Shionogi’s antibacterial therapy Fetroja (cefiderocol) has secured approval in the US for the treatment of complicated urinary tract infections (cUTI), …
Label expansion of Amarin’s Vascepa has unanimous backing of FDA advisory panel
November 15, 2019Medical Communications, Sales and Marketing Amarin, FDA, vascepa
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted in favour of expanding the existing approval of Irish …
Top Ten most popular articles on Pharmafile.com this week
November 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
As we close in on the weekend, it’s been a week characterised by data reveals and crucial marketing approvals, including …
AstraZeneca’s Qtrilment scores European authorisation in type 2 diabetes
November 15, 2019Medical Communications, Sales and Marketing AstraZeneca, EU, Europe, Qtrilmet, diabetes, pharma, type 2 diabetes
Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) has secured approval in Europe, its manufacturer AstraZeneca has revealed, as a therapy to …
New report reveals shocking knowledge gaps around type 2 diabetes risk factors
November 14, 2019Medical Communications, Research and Development Merck KGaA, diabetes, pharma, type 2 diabetes
A new report released on World Diabetes Day has shone a light on a startling lack of knowledge surrounding type …
FDA advisory committee votes down approval of Boehringer and Lilly’s drug for type 1 diabetes
November 14, 2019Sales and Marketing Boehringer Ingelheim, Eli Lilly, empagliflozin, jardiance, pharma
Boehringer Ingelheim and Eli Lilly’s have been dealt a blow from the FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC), …
Myeloma UK reveals new Director of Research appointment
November 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Myleoma UK, appointment, multiple myeloma, pharma
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, who in her new role …
NICE greenlights Consilient Health’s Elmiron for bladder pain syndrome
November 14, 2019Sales and Marketing NICE, consilient health, elmiron, pharma
NICE has chosen to recommend Consilient Health’s Elmiron (pentosan polysulfate sodium) for the treatment of bladder pain syndrome (BPS), it …
MSD’s proposed sale of French manufacturing plant puts over 200 jobs in jeopardy
November 14, 2019Manufacturing and Production France, MSD, pharma
MSD has announced its plans to put its Centre de Mirabel production facility in Riom, France up for sale – …
Wearable tech market set to double to $54 billion by 2023, report says
November 13, 2019Research and Development, Sales and Marketing pahrma, wearble technology
A new report from GlobalData has revealed that the market for wearable technology in healthcare is expected to more than …
Abbott CEO to step down after 21 years
November 13, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbott, appointment
After more than two decades at the head of the company, it has emerged that Miles D White (pictured, right) …
Vertex’s cystic fibrosis portfolio to be made available across Northern Ireland and Wales
November 13, 2019Research and Development, Sales and Marketing Kalydeco, NHS, Orkambi, Symkevi, Vertex, pharma
After drawn out negotiations and much discontent among cystic fibrosis (CF) patients and their advocates, Vertex has announced that a …
Mylan and Upjohn merger will create a new entity: Viatris
November 13, 2019Manufacturing and Production, Research and Development, Sales and Marketing Mylan, Pfizer, Upjohn, Viatris, pharma
The name for the new company emerging out of the merger between Pharma firm Mylan and Pfizer division Upjohn has …
GSK’s Nucala meets Phase 3 goal in reducing hypereosinophilic syndrome flare-ups
November 13, 2019Research and Development GSK, Nucala, pharma
GlaxoSmithKline has unveiled new Phase 3 data for its IL-5 inhibitor Nucala (mepolizumab), revealing that the therapy met its primary …
Pfizer’s tofacitinib hits main goal in Phase 3 juvenile idiopathic arthritis study
November 12, 2019Manufacturing and Production, Research and Development Pfizer, pharma, tofacitinib
Pfizer has lifted the lid on new Phase 3 data exploring the efficacy of tofacitinib in the treatment of juvenile …
Scottish Medicines Consortium recommends Eisai’s Kisplyx for advanced kidney cancer
November 12, 2019Manufacturing and Production, Sales and Marketing Eisai, Kisplyx, NHS, Sotland, pharma
Eisai’s Kisplyx (lenvatinib) has secured recommendation from the Scottish Medicines Consortium, it has been revealed, meaning that patients on the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
